Intercept Pharmaceuticals Inc (was acquisited by Alfasigma (Italy) on 08/11/2023) (ICPT)
(10% Negative) Intercept Pharmaceuticals, Inc. (ICPT) Announces Delay in data Trials for alkaline phosphatase (ALP) Due to Pandemic-Related Challenges, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment
📋 Intercept Pharmaceuticals, Inc. (ICPT) - Clinical Trial Update
Filing Date: 2022-06-03
Accepted: 2022-06-03 07:45:26
Event Type: Clinical Trial Update
Event Details:
🔬 Clinical Development Pipeline (Intercept Pharmaceuticals, Inc.):
💼 Business Developments:
Structured Data: